Pregnancy-specific urinary incontinence in women with gestational hyperglycaemia worsens the occurrence and severity of urinary incontinence and quality of life over the first year post partum.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 24 02 2019
revised: 15 06 2020
accepted: 19 06 2020
pubmed: 14 7 2020
medline: 15 5 2021
entrez: 14 7 2020
Statut: ppublish

Résumé

To determine the occurrence and severity of pregnancy-specific urinary incontinence (PSUI) in women with gestational hyperglycaemia, and its impact on quality of life (QoL) over the first year post partum. Three hundred and eighty-eight pregnant women with PSUI were distributed into two groups (normoglycaemic and hyperglycaemic) and analysed at five timepoints during pregnancy and the first year post partum. Gestational hyperglycaemia was defined according to the criteria of the American Diabetes Association and the glucose profile test. Relationships with outcome were analysed using Chi-squared test for categorical variables and Student's t-test for quantitative variables. The overall prevalence rate of PSUI was 54.1 %, with prevalence rates of 43.3 % and 56.7 % in normoglycaemic and hyperglycaemic Brazilian pregnant women, respectively. Women with gestational hyperglycaemia had a higher amount of urine loss (p < 0.0027), frequency of UI (p < 0.0014), impact of UI on QoL (p < 0.0001), severity of UI (p = 0.0003) and total scores on the International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form (ICIQ-SF) and Incontinence Severity Index (ISI) (p<0.0001) at the two timepoints during pregnancy; and a higher amount of urine loss (p = 0.0079), frequency of UI (p = 0.0382), impact of UI on QoL (p < 0.0001), severity of UI (p = 0.0053) and questionnaire scores (p < 0.0001 for ICIQ-SF and p = 0.003 for ISI) over the first year post partum. PSUI in women with gestational hyperglycaemia worsens the occurrence and severity of UI, and the impact of UI on QoL over the first year post partum. These results emphasize the interaction between PSUI, gestational hyperglycaemia and long-term maternal outcome.

Identifiants

pubmed: 32659639
pii: S0301-2115(20)30403-6
doi: 10.1016/j.ejogrb.2020.06.036
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

336-343

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None declared.

Auteurs

Fernanda Piculo (F)

Perinatal Diabetes Research Center, Department of Gynecology and Obstetrics, Botucatu Medical School, Univ Estadual Paulista_UNESP, Botucatu, São Paulo, Brazil. Electronic address: fer_piculo@yahoo.com.br.

Gabriela Marini (G)

Perinatal Diabetes Research Center, Department of Gynecology and Obstetrics, Botucatu Medical School, Univ Estadual Paulista_UNESP, Botucatu, São Paulo, Brazil.

Giovana Vesentini (G)

Perinatal Diabetes Research Center, Department of Gynecology and Obstetrics, Botucatu Medical School, Univ Estadual Paulista_UNESP, Botucatu, São Paulo, Brazil.

Glilciane Morceli (G)

Perinatal Diabetes Research Center, Department of Gynecology and Obstetrics, Botucatu Medical School, Univ Estadual Paulista_UNESP, Botucatu, São Paulo, Brazil.

Débora C Damasceno (DC)

Perinatal Diabetes Research Center, Department of Gynecology and Obstetrics, Botucatu Medical School, Univ Estadual Paulista_UNESP, Botucatu, São Paulo, Brazil.

Luis Sobrevia (L)

Cellular and Molecular Physiology Laboratory, Division of Obstetrics and Gynecology, School of Medicine, Faculty of Medicine, Pontifical Catholic University of Chile, Santiago, Chile; Department of Physiology, Faculty of Pharmacy, Universidad De Sevilla, Seville, Spain; University of Queensland Centre for Clinical Research, Faculty of Medicine and Biomedical Sciences, University of Queensland, Herston, Queensland, Australia.

Angélica M P Barbosa (AMP)

Perinatal Diabetes Research Center, Department of Gynecology and Obstetrics, Botucatu Medical School, Univ Estadual Paulista_UNESP, Botucatu, São Paulo, Brazil.

Marilza V C Rudge (MVC)

Perinatal Diabetes Research Center, Department of Gynecology and Obstetrics, Botucatu Medical School, Univ Estadual Paulista_UNESP, Botucatu, São Paulo, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH